drugset / Trial / NCT07532135

Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer

NCT07532135 ↗

Phase 1 Recruiting 48 enrolled Chulalongkorn University
RandomizedParallel-groupTriple-blindOther

Summary

Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.

Timeline

Start
2025-10-01
Primary completion
2026-09-01
Completion
2026-09-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Mulberry leaf extract Unknown 12 mg —

Indications